US BANCORP \DE\ - CHECKMATE PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 35 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$6,0000.0%2,0000.0%0.00%–
Q4 2021$6,000
-25.0%
2,0000.0%0.00%–
Q3 2021$8,000
-33.3%
2,0000.0%0.00%–
Q2 2021$12,000–2,000–0.00%–
 Download
Other shareholders

There were no reported owners of CHECKMATE PHARMACEUTICALS IN in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders